Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...